Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35 (last close)
Last close data
🏠 Home   ➤    Stock news

Amoéba Wins Gold Medal at SIVAL for its Biocontrol Solution

Lyon-based greentech company Amoéba has won the gold medal at the SIVAL Innovation Contest 2026 for its AXPERA biocontrol solution, according to a press release issued this Monday. The company and its partner Koppert are preparing for the commercial launch of this solution aimed at vineyards and vegetable crops, pending European approvals.


Amoéba Wins Gold Medal at SIVAL for its Biocontrol Solution

Recognition at SIVAL 2026

At the 2026 edition of SIVAL in Angers, the jury evaluated 34 innovations across 7 categories, the press release states. Amoéba's AXPERA solution, presented in the plant health, soil and growing media category, won the gold medal. The award ceremony took place on January 14 during an official evening event. During the fair, Koppert held a press conference on January 13 to announce the international launch of the TIAGAN brand, which will replace AXPERA for viticultural uses, according to the company. This step solidifies the collaboration that has been underway between the two partners for several months.

Strategic Developments in 2025

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

In June 2025, the active substance of Willaertia magna C2c Maky lysate was approved by the 27 EU member states as a low-risk substance, the group recalls. Amoéba also signed a strategic commercial agreement with Koppert, a global leader in biocontrol, granting it exclusive distribution rights for 5 years for vineyards and vegetable crops in 18 European countries and the United States. In October 2025, the company received market authorization in the United States for AXPERA and was awarded the Gold Medal of the Bernard Blum Award. In November 2025, a memorandum of understanding was signed with Syngenta to develop and market biocontrol solutions for the European Union and UK markets, prioritizing cereals and field crops, according to the press release.

Future Prospects and Market Authorization

Amoéba is now awaiting market authorization for the TIAGAN solution in 9 targeted European countries, with a decision expected in the first half of 2026, the company indicates. The company continues its collaboration with Koppert to implement the marketing strategy in the initial targeted European countries, particularly France and Italy, during the course of 2026. Vineyards and vegetable crops will be prioritized. Concurrently, Amoéba continues its investments with subcontractors to prepare for the ramp-up of production, according to the press release. The solution aims to enable vine growers to reduce the use of copper while enhancing the efficacy of plant protection programs, the group specifies.



Sector Chimie Produits Chimiques Spécialisés


Assurance vie

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit